Cutaneous leishmaniasis with lymphadenopathy due to<i>Leishmania donovani</i>

Faber, William R.; Wonders, J.; Jensema, Annigje J.; Chocholová, Eva; Kager, Piet A.

doi:10.1111/j.1365-2230.2008.02996.x

Cited by 8 publications

(2 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Patients were diagnosed in 35 countries; most of the cases were in the Middle East, Europe, and North America (Table 1). In these three regions, countries with the largest share of diagnosis were Lebanon (57.0%, [192,282]), France (13.4%, [6,61,81,108,121,134,136,193], the USA (6.1%, [72,80,84,88,92,93,110,114,117,120,122,123,127,139,141,142,149,150,159,163,169,175,179,180,197,221,224,229,234,235,238,239,243,244,247,263,266,279]), the Netherlands (5.0%, …”

Section: Cutaneous Mucocutaneous and Mucosal Leishmaniasismentioning

confidence: 99%

Non-Endemic Leishmaniases Reported Globally in Humans between 2000 and 2021—A Comprehensive Review

Rocha¹,

Pereira

Maia³

2022

Pathogens

View full text Add to dashboard Cite

Leishmaniases are human and animal parasitic diseases transmitted by phlebotomine sand flies. Globalization is an important driver of the burden and in the current dynamics of these diseases. A systematic review of articles published between 2000 and 2021 was conducted using the PubMed search engine to identify the epidemiology and clinical management of imported human leishmaniases as a fundamental step to better manage individual cases and traveler and migrant health from a global perspective. A total of 275 articles were selected, representing 10,341 human imported cases. Identified drivers of changing patterns in epidemiology include conflict and war, as well as host factors, such as immunosuppression, natural and iatrogenic. Leishmania species diversity associated with different clinical presentations implies diagnostic and treatment strategies often complex to select and apply, especially in non-endemic settings. Thus, diagnostic and management algorithms for medical clinical decision support are proposed. Increased surveillance of non-endemic cases, whether in vulnerable populations such as refugees/migrants and immunocompromised individuals or travelers, could improve individual health and mitigate the public health risk of introducing Leishmania species into new areas.

show abstract

Section: Cutaneous Mucocutaneous and Mucosal Leishmaniasismentioning

confidence: 99%

Non-Endemic Leishmaniases Reported Globally in Humans between 2000 and 2021—A Comprehensive Review

Rocha¹,

Pereira

Maia³

2022

Pathogens

View full text Add to dashboard Cite

show abstract

“…4 However, data on the treatment of CL with miltefosine are limited, [5][6][7][8] and the efficacy of miltefosine against CL caused by the L. donovani/infantum complex has been documented in only two patients. 9,10 We report on a case of imported CL that was successfully treated with miltefosine, and on the follow-up investigation, which revealed a hitherto undescribed strain of the L. donovani/infantum complex.…”

Section: Introductionmentioning

confidence: 99%